[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Contact

Faster, Cleaner, Better.

quotes
- Price Overview
- Performance Report
charts
- Interactive Chart
- Snapshot Chart
technicals
options
options strategies
company
analysts
- Earnings Estimates
- Analyst Ratings
financials

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

News & Headlines for [[ item.sessionDateDisplayLong ]]

Notes

Alerts

Watch

Help

1 Unprofitable Stock for Long-Term Investors and 2 Facing Headwinds StockStory - Thu Jun 18, 11:34PM CDT

1 Unprofitable Stock for Long-Term Investors and 2 Facing Headwinds

NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes Business Wire - Wed Jun 17, 5:00AM CDT

NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of oncology diagnostic solutions that enable precision medicine, announced today the pricing of its previously announced private offering of...

NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes Business Wire - Mon Jun 15, 4:24PM CDT

NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of oncology diagnostic solutions that enable precision medicine, announced today that it has commenced a private offering of $275 million aggregate...

NeoGenomics to Present New Research at ASCO Annual Meeting 2026 Business Wire - Tue May 26, 6:05AM CDT

Presentations highlight advances in MRD, precision oncology, and real-world evidence across solid tumors and hematologic malignancies

NeoGenomics to Participate in Upcoming Investor Conferences Business Wire - Fri May 15, 8:05AM CDT

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the following investor conferences:...